Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Konstantinopoulos, Panagiotis A.; Waggoner, Steven; Vidal, Gregory A.; Mita, Monica; Moroney, John W.; Holloway, Robert; Van Le, Linda; Sachdev, Jasgit C.; Chapman-Davis, Eloise; Colon-Otero, Gerardo; Penson, Richard T.; Matulonis, Ursula A.; Kim, Young Bae; Moore, Kathleen N.; Swisher, Elizabeth M.; Farkkila, Anniina; D'Andrea, Alan; Stringer-Reasor, Erica; Wang, Jing; Buerstatte, Nathan; Arora, Sujata; Graham, Julie R.; Bobilev, Dmitri; Dezube, Bruce J.; Munster, Pamela

authors

Publication Date

  • August 1, 2019

webpage

published in

category

start page

  • 1141

end page

  • 1149

volume

  • 5

issue

  • 8